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Abstract
Although they are primitive vertebrates, zebrafish (Danio rerio) and medaka (Oryzias latipes) have surpassed other
animals as the most used model organisms based on their many advantages. Studies on gene expression patterns,
regulatory cis-elements identification, and gene functions can be facilitated by using zebrafish embryos via a
number of techniques, including transgenesis, in vivo transient assay, overexpression by injection of mRNAs,
knockdown by injection of morpholino oligonucleotides, knockout and gene editing by CRISPR/Cas9 system and
mutagenesis. In addition, transgenic lines of model fish harboring a tissue-specific reporter have become a powerful
tool for the study of biological sciences, since it is possible to visualize the dynamic expression of a specific gene in
the transparent embryos. In particular, some transgenic fish lines and mutants display defective phenotypes similar
to those of human diseases. Therefore, a wide variety of fish model not only sheds light on the molecular
mechanisms underlying disease pathogenesis in vivo but also provides a living platform for high-throughput
screening of drug candidates. Interestingly, transgenic model fish lines can also be applied as biosensors to detect
environmental pollutants, and even as pet fish to display beautiful fluorescent colors. Therefore, transgenic model
fish possess a broad spectrum of applications in modern biomedical research, as exampled in the following review.
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Background
Although zebrafish (Danio rerio) and medaka (Oryzias
latipes) are primitive vertebrates, they have several
advantages over other model animals. For example, they
are fecund and light can control their ovulation. Spawn-
ing takes place frequently and no limitation in their
spawning season. Microinjection of fertilized eggs is eas-
ily accessible and relatively cheap. Their embryos are
transparent, making it easy to monitor the dynamic gene
expression in various tissues and organs in vivo without
the need to sacrifice the experimental subjects. Their
genome sizes are approximately 20 to 40 % of the mam-
malian genome, making them the only vertebrates
available for large-scale mutagenesis. Their maturation
time takes only 2 ~ 3 months, which is relatively less
laborious and time-saving for generating transgenic
lines. In addition, many routine techniques of molecular
biology and genetics, including knock-in, knockdown and
knockout, are well developed in the model fish. Therefore,
zebrafish and medaka are new excellent animal systems
for the study of vertebrate-specific biology in vivo.
Review
Germline transmission
The F0 transgenic line can be established once the
exogenous gene can be successfully transferred to the
embryos, followed by stable germline transmission of the
transgene to the F1 generation. Generally, around 10–20 %
of treated embryos have a chance to achieve germline
transmission [1]. It has been reported that a foreign gene
flanked with inverted terminal repeats of adeno-associated
virus can be used to enhance the ubiquitous expression
and stable transmission of transgene in model fish [2].
Meanwhile, transgenesis can be facilitated by using the
Tol2 transposon derived from medaka [3]. Transposase
catalyzes transposition of a transgene flanked with the Tol2
sequence [4]. The efficiency of Tol-2-mediated germline
transmission could range from 50 to 70 % of injected
embryos [4, 5].
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A cutting-edge technique has taken the study of fish
gene transfer to new horizons, such as knockout zebra-
fish by the transcription activator-like effector nuclease
(TALEN) system and the clustered regularly interspaced
short palindromic repeats (CRISPR) combined with
CRISPR-associated proteins 9 (Cas9) [6, 7]. The TALEN
system involves the DNA recognition domain of tran-
scription activator-like effectors (TALEs) and a nuclease
domain for generation of nicks on DNA sequences. The
CRISPR/Cas9 system directed by a synthetic single guide
RNA can induce targeted genetic knockout in zebrafish.
The main difference between these two systems is
based on their recognition mechanisms. Unlike the
TALEs applied in the TALEN system, the CRISPR/Cas9
system recognizes its target DNA fragment by the com-
plementary non-coding RNA. The development of the
TALEN and CRISPR/Cas9 systems provides new gen-
omic editing approaches for establishing genetic knock-
out fish lines [8].
Transgenic fluorescent fish
The fluorescence protein gene (FPG) has been widely
applied as a reporter gene in studies of the transgene
expression by direct visualization under fluorescent
microscopy in vivo [9]. Many transgenic model fish lines
harbor an FPG driven by various tissue-specific pro-
moters, including the erythroid-specific GATA promoter
[10], muscle-specific α-actin promoter [11], rod-specific
rhodopsin promoter [12], neuron-specific isl-1 promoter
[13], pancreas-specific pdx-1 and insulin promoters [14],
myocardium-specific cmlc2 promoter [15], liver-specific
L-FABP promoter [16], bone-specific col10a1 promoter
[17], macrophage-specific mfap4 promoter [18], and germ
cell-specific vasa promoter [19]. Using medaka β-actin
promoter, Tsai’s lab generated a transgenic line of medaka
displaying green FP ubiquitously around the whole fish
from F0 through F2 generations in a Mendelian inherit-
ance manner [20]. This is known as the first transgenic
line of glowing pet fish, which was reported by Science
[21] and Far Eastern Economic Review [22] and honored
to be selected as among “The Coolest Inventions of
2003” by TIME [23]. The DNA sequences of the afore-
mentioned promoters ranging from 0.5 to 6.5 kb are suffi-
cient to drive the FPG reporter to mimic the tissue-specific
expression of endogenous gene.
However, some genes require a longer regulatory DNA
sequence, such as more than 20 kb, to fully recapitulate
the characteristic expression profiles of endogenous
genes. In that case, bacterial artificial chromosome
(BAC) and phage P1-dereived artificial chromosome
(PAC) have been commonly used for this purpose [24].
For example, the zebrafish rag1 gene, flanked with PAC
DNA containing 80 kb at the 5′ upstream and 40 kb at
the 3′ downstream, can be expressed specifically in
lymphoid cells. Instead of using the tedious Chi-site
dependent approach, Jessen et al. reported a two-step
method to construct a BAC clone [25]. Employing this
protocol, Chen et al. constructed a BAC clone containing
the upstream 150 kb range of zebrafish myf5 and gener-
ated a transgenic line Tg (myf5:gfp) [26]. This transgenic
line is able to recapitulate the somite-specific and stage-
dependent expression of the endogenous myf5 at an early
developmental stage. In summary, all the above transgenic
lines should be very useful materials for studying both
gene regulation and cell development.




Zebrafish is particularly useful for studying heart develop-
ment for the following reasons: (a) Zebrafish have a primi-
tive form of the heart, which is completely developed
within 48 h post-fertilization (hpf). (b) The cardiac devel-
opment can be easily observed in the transgenic line pos-
sessing a FP-tagged heart. (c) The zebrafish embryos with
a defective cardiovascular system can still keep on growing
by acquiring oxygen diffused from water. (d) Discovery of
genes involved in heart development can be facilitated by
a simple haploid mutation method [27]. For example,
using the zebrafish jekyll mutant, which has defective
heart valves, Walsh and Stainier discovered that UDP-
glucose dehydrogenase is required for zebrafish embryos
to develop normal cardiac valves [28].
Tsai’s lab is the first group to generate a transgenic
zebrafish line that possesses a GFP-tagged heart [15].
This line was established from zebrafish embryos intro-
duced with an expression construct, in which the GFP
reporter is driven by an upstream control region of zeb-
rafish cardiac myosin light chain 2 gene (cmlc2). Using
this transgenic line, Raya et al. found that the Notch sig-
naling pathway is activated is during the regenerative re-
sponse [29]. Shu et al. reported that Na, K-ATPase α1B1
and α2 isoforms have distinct roles in the patterning of
zebrafish heart [30]. This transgenic line should also be
useful for studying the dynamic movement and cell fate
of cardiac primordial cells. For example, Forouhar et al.
proposed a hydro-impedance pump model for the em-
bryonic heart tubes of zebrafish [31]. A 4D dynamic
image of cardiac development has been developed [32].
Furthermore, Hami et al. reported that a second heart
field is required during cardiac development [33]. Thus,
recently, Nevis et al. stated that tbx1 plays a function for
proliferation of the second heart field, and the zebrafish
tbx1-null mutant resemble the heart defects in DiGeorge
syndrome [34].
Thus, the expression pattern of heart-specific genes
could be analyzed based on heart progenitor cells collected
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in this transgenic line. The analysis of gene or protein ex-
pression dynamics at different developmental stages could
also be conducted. Furthermore, this transgenic fish is
a potential platform for detecting chemicals, drugs
and environmental pollutants affecting heart development,
as detailed in following section.
Muscle development
In vivo transient assay of the injected DNA fragments in
model fish embryos is a simple yet effective way to analyze
the function of regulatory cis-elements. For example,
Myf5, one of myogenesis regulatory factors (MRF), plays
key roles in the specification and differentiation of muscle
primordial cells during myogenesis. The expression of
myf5 is somite-specific and stage-dependent, and its acti-
vation and repression are delicately orchestrated. Using in
vivo transient assay, Chen et al. found that a novel cis-
element located at −82/-62 is essential for somite-specific
expression of myf5 [35]. Lee et al. revealed that this −82/-
62 cis-element is specifically bound by Forkhead box D3,
and proposed that somite development is regulated by the
Pax3-FoxD3-Myf5 axis [36]. Besides FoxD3, FoxD5, an-
other protein in the Forkhead box family, is necessary for
maintaining the anterior-posterior polarity of somite cells
in mesenchymal-epithelial transition [37]. The expression
of FoxD5 is regulated by Fgf signaling in anterior pre-
somitic mesoderm (PSM), which indicates that Fgf-
FoxD5-Mesp signaling takes place in somitogenesis [37].
Furthermore, analysis of the loci of adjacent mrf4 and
myf5 revealed the complicated regulation mechanism of
the MRF genes. It was also found that the biological func-
tion of Mrf4 is related to myofibril alignment, motor axon
growth, and organization of axonal membrane [38].
The molecular mechanism that underlies the repression
of myf5 has also been reported. For example (Fig. 1a), a
strong repressive element of zebrafish myf5 was found
within intron I (+502/+835) [39]. This repressive element
is modulated by a novel intronic microRNA, termed miR-
In300 or miR-3906 [40]. When myf5 transcripts reach the
highest level after specification, the accumulated miR-
3906 starts to reduce the transcription of myf5 through si-
lencing the positive factor Dickkopf-related protein 3
(Dkk3r or Dkk3a) for the myf5 promoter [41]. Itgα6b is a
receptor of secretory Dkk3a and that interaction between
Itgα6b and Dkk3a is required to drive the downstream sig-
nal transduction which regulates myf5 promoter activity
in somite during embryogenesis of zebrafish [42].
Dkk3a regulates p38a phosphorylation to maintain
Smad4 stability, which in turn enables the formation of
the Smad2/3a/4 complex required for the activation of the
myf5 promoter [43]. However, when myf5 transcripts are
reduced at the later differentiation stage, miR-3906 is able
to be transcribed by its own promoter [40] (Fig. 1b).
Furthermore, increased expression of miR-3906
Fig. 1 miR-3906 silences different target genes at different muscle developmental stages. a At the early muscle development, Dkk3a
interacts with its receptor Itgα6b, resulting in the phosphorylation of p38a and the formation of the Smad2/3a/4 complex, which in turn,
activates the myf5 promoter activity. When myf5 is highly transcribed, the intronic miR-3906 suppresses the transcription of myf5 through
silencing the Dkk3a [39, 41–43]. b At the late muscle development, miR-3906 starts transcription at its own promoter and switches to silence
homer1b to control the homeostasis of intracellular calcium concentration ([Ca2+]i) in fast muscle cells [40]. Either miR-3906-knockdown or homer-
1b-overexpression causes the increase of Homer-1b protein, resulting in an enhanced level of [Ca2+]i, which in turn, disrupts sarcomeric actin fila-
ment organization. In contrast, either miR-3906-overexpression or homer-1b-knockdown causes the decrease of Homer-1b, resulting in a reduced
[Ca2+]i and thus a defective muscle phenotype [40]
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controls the intracellular concentration of Ca2+ ([Ca2+]i)
in fast muscle cells through subtly reducing homer-1b ex-
pression. The homeostasis of [Ca2+]i is required during
differentiation to help maintain normal muscle develop-
ment [40]. Nevertheless, it remains to be investigated
how miR-3906 switches its target gene at different de-
velopmental stages.
Apart from the regulation of somitogenesis, Myf5 is
also involved in craniofacial muscle development. The
functions of Myf5 in cranial muscles and cartilage devel-
opment are independent of Myod, suggesting that Myf5
and Myod are not redundant. Thus, three possible path-
ways could be associated with the molecular regulation
between Myf5 and Myod: (i) Myf5 alone is capable of
initiating myogenesis, (ii) Myod initiates muscle primor-
dia, which is subdivided from the myf5-positive core,
and (iii) Myod alone, but not Myf5, modulates the devel-
opment of muscle primordia [44]. Furthermore, the
six1a gene was found to play an important role in the
interaction between Myf5 and Myod [45]. In cartilage
development, myf5 is expressed in the paraxial meso-
derm at the gastrulation stage. Myf5 plays a role in
mesoderm fate determination by maintaining the expres-
sion of fgf3/8, which in turn, promotes differentiation
from neural crest cells to craniofacial cartilage [46]. This
research on myf5 not only reveals that it has different
functions between craniofacial muscle development and
somitogenesis, but it also opens up a new study field for
understanding craniofacial muscle development.
Hinits et al. reported no phenotype both in myf5-
knockdown embryos and myf5-null mutant, suggesting
that Myf5 is rather redundant in somitogenesis of
zebrafish [47]. However, it is hard to reasonably ex-
plain why these embryos and mutant are all lethal
and can’t grow to adulthood. On the other hand, Lin
et al. reported an observable defective phenotype in
myf5-knockdown embryos, and claimed that the con-
centration of myf5-MO they used can inhibit maternal
myf5 mRNA translation [46]. This discrepancy might
attribute the effectiveness of MO used or the different
phenotypes between the knockdown embryos and
knockout mutant in this case.
Ocular and nerve development
The retina-specific expression of the carp rhodopsin
gene is controlled by two upstream regulatory DNA cis-
elements [48]. One is located at −63 to −75, which is the
carp neural retina leucine zipper response-like element;
the other is located at −46 to −52, which is a carp-
specific element crucial to reporter gene expression in
medaka retinae. Intriguingly, immediate activation of
early growth response transcriptional regulator Egr1
could result in the incomplete differentiation of retina
and lens, leading to microphthalmos [49]. Another
important factor for ocular development is the ADP-
ribosylation factor-like 6 interacting protein 1 (Arl6ip1).
Loss of Arl6ip1 function leads to the absence of retinal
neurons, disorganized retinal layers and smaller optic
cups [50]. Upon losing Arl6ip1, retinal progenitors con-
tinued to express cyclin D1, but not shh or p57kip2,
suggesting that eye progenitor cells remained at the
early progenitor stage, and could not exit the cell cycle
to undergo differentiation [51]. Additionally, it has been
reported that Arl6ip1 is essential for specification of
neural crest derivatives, but not neural crest induction.
Tu et al. found that Arl6ip1 mutation causes abnormal
neural crest derivative tissues as well as reduced ex-
pression of neural crest specifier genes, such as foxd3,
snail1b and sox10, indicating that Arl6ip1 is involved in
specification, but not induction, of neural crest cells
[52]. Furthermore, they found that Arl6ip1 could play
an important role in the migration of neural crest
cells because in the arl6ip1-knockdown embryos, crestin-
and sox10-expressing neural crest cells failed to migrate
ventrally from neural tube into trunk. More recently,
Lin et al. found that Ras-related nuclear (Ran) protein
is conjugated with Arl6ip1, and proposed that Ran
protein associates with Arl6ip1 to regulate the devel-
opment of retinae [53].
To date, no in vivo model system has been established
to identify cells in the CNS that can specifically respond
with regeneration after stresses, and, even if identified,
no method is in place to trace these responsive cells and
further identify their cell fates during hypoxic regener-
ation. To address these issues, Lee et al. generated a trans-
genic zebrafish line huORFZ, which harbors the upstream
open reading frame (uORF) from human CCAAT/enhan-
cer-binding protein homologous protein gene (chop),
fused with the GFP reporter and driven by a cytomegalo-
virus promoter [54]. After huORFZ embryos were treated
with heat-shock or under hypoxia, the GFP signal was ex-
clusively expressed in the CNS, resulting from imped-
ing the huORFchop-mediated translation inhibition
[54]. Interestingly, Zeng et al. found that GFP-(+)
cells in spinal cord respond to stress, survive after
stress and differentiate into neurons during regener-
ation (Chih-Wei Zeng, Yasuhiro Kamei and Huai-Jen
Tsai, unpublished data).
MicroRNAs and development
MicroRNAs (miRNAs) are endogenous single-stranded
RNA molecules of 19–30 nucleotides (nt) that repress or
activate the translation of their target genes through
canonical seed- and non-canonical centered miRNA
binding sites. The known mechanisms involved in
miRNAs-mediated gene silencing are decay of mRNAs
and blockage of translation [55–57]. Probably the ex-
pression of 30 ~ 50 % of human genes is regulated by
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miRNAs [58, 59]. Therefore, to understand gene and
function in cells or embryos, it is important to exactly
know the target gene(s) of a specific miRNA at differ-
ent phase of cells or at particular stages of developing
embryos.
Instead of using a bioinformatic approach, the Tsai’s lab
developed the Labeled miRNA Pull-down (LAMP) assay
system, which is a simple but effective method to search
for the candidate target gene(s) of a specific miRNA under
investigation [60]. LAMP assay system yields fewer false-
positive results than a bioinformatic approach. Taking
advantage of LAMP, scientists discovered that miR-3906
silences different target genes at different developmental
stages, e.g., at early stage, miR-3906 targets dkk3a [41],
while at late stage, it targets homer-1b [40] (Fig. 1).
In another example (Fig. 2), miR-1 and miR-206 are two
muscle-specific microRNAs sharing the same seed se-
quences. They are able to modulate the expression of
vascular endothelial growth factor Aa (VegfAa) and serve
as cross-tissue signaling regulators between muscle and
vessels. Since miR-1 and miR-206 share identical seed se-
quences, Stahlhut et al. demonstrated that they can silence
the same target gene, such as vegfaa, and considered them
as a single cross-tissue regulator termed as miR-1/206 [61].
miR-1/206 reduces the level of VegfAa, resulting in the in-
hibition of the angiogenic signaling [61]. Surprisingly, using
the LAMP assay system, Lin et al. reported that the target
genes for miR-1 and miR-206 are different [62]. While
miR-206 targets vegfaa, miR-1 targets seryl-tRNA synthe-
tase gene (sars). SARS is a negative regulator of VegfAa.
Although both miR-1 and miR-206 have identical seed se-
quences, the sars-3′UTRs of zebrafish, human and mouse
origins can be recognized only by miR-1 in zebrafish em-
bryos and mammalian cell lines (HEK-293 T and C2C12),
but not by miR-206 [62]. Conversely, the vegfaa-3′UTR is
targeted by miR-206, but not by miR-1. Therefore, Lin et al.
concluded that miR-1 and miR-206 are actually two distinct
regulators and play opposing roles in zebrafish angiogen-
esis. The miR-1/SARS/VegfAa pathway promotes embry-
onic angiogenesis by indirectly controlling VegfAa, while
miR-206/VegfAa pathway plays an anti-angiogenic role by
directly reducing VegfAa. Interestingly, they also found that
the miR-1/SARS/VegfAa pathway increasingly affects em-
bryonic angiogenesis at late developmental stages in somitic
cells [62]. It remains to be studied how miR-1 increases in
abundance at late stage.
miRNAs in regeneration
Different from mammals, zebrafish have the ability to re-
generate injured parts in the CNS. Many miRNAs have
been found in the CNS. Since miRNAs are involved in
many aspects of development and homeostatic pathways,
they usually play important roles in regeneration [63]. It
has been shown that several miRNAs have prominent
Fig. 2 miR-1 and miR-206 silence different target genes and play opposing roles in zebrafish angiogenesis. Both miR-1 and miR-206 are muscle-
specific microRNAs and share identical seed sequences. However, they silence different target genes to affect the secreted VegfAa level through
different pathways [62]. The miR-1/SARS/VegfAa pathway plays a positive role in angiogenesis since SARS, a negative factor for VegfAa
promoter transcription, is silenced by miR-1, resulting in the increase of VegfAa. However, the miR-206/VegfAa pathway plays a negative role since
VegfAa is silenced directly by miR-206. Dynamic changes of miR-1 and miR-206 levels are also observed [62]. The miR-1 level gradually increases
between 12 and 20 hpf and significantly increases further between 20 and 32 hpf, while the miR-206 level is only slightly changed during this same
period. Consequently, VegfAa increases greatly from 24 to 30 hpf, which might be responsible for the continuous increase of miR-1/SARS/VegfAa
pathway, but not miR-206/VegfAa pathway. Therefore, temporal regulation of the expression of miR-1 and miR-206 with different target genes occur during
embryonic angiogenesis in somitic cells of zebrafish
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functions in regulating the regeneration process. For ex-
ample, miR-210 promotes spinal cord repair by enhancing
angiogenesis [64], and the miR-15 family represses prolif-
eration in the adult mouse heart [65]. Furthermore, miR-
NAs miR-29b and miR-223 are identified following optic
nerve crush. By gene ontology analysis, miR-29b and miR-
223 are found to regulate genes, including eva1a, layna,
nefmb, ina, si:ch211-51a6.2, smoc1, and sb:cb252. These
genes are involved in cell survival or apoptosis, indicating
that these two miRNAs are potential regulators of optic
nerve regeneration [66].
Hematopoiesis
Although the main hematopoietic sites in zebrafish differ
from those in mammals, both zebrafish and mammals
share all major blood cell types that arise from common
hematopoietic lineages [67]. Moreover, many genes and
signaling pathways involved in hematopoiesis are con-
served among mammals and zebrafish. For example, scl,
one of the first transcription factors expressed in early
hematopoietic cells, is evolutionarily conserved. During de-
finitive hematopoiesis, runx1 marks hematopoietic stem
cells (HSCs) in both mouse and fish. Additionally, in differ-
entiated populations, gata1, the erythroid lineage regulator,
pu.1 and c/ebp, the myeloid lineage regulators, and ikaros,
a mark of the lymphoid population, are in accordance with
the hematopoietic hierarchy in zebrafish and mammals
[68]. Thus, the findings with respect to zebrafish blood de-
velopment could be applied to mammalian system.
Genetic screening in zebrafish has generated many
blood-related mutants that help researchers understand
hematopoietic genes and their functions [69]. For ex-
ample, the spadetail mutant carrying a mutated tbx16 ex-
hibits defective mesoderm-derived tissues, including
blood. This mutant displays the decrease levels tal1, lmo2,
gata2, fli1 and gata1 in the posterior lateral mesoderm, in-
dicating the important role of tbx16 during hemangioblast
regulation [70]. Chemical screening in zebrafish using bio-
logically active compounds is also a powerful approach to
identify factors that regulate HSCs. For example, it is well
known that prostaglandin (PG) E2 increases the induction
of stem cells in the aorta–gonad–mesonephros region of
zebrafish, as demonstrated by increasing expressions of
runx1 and cmyb, which, in turn, increases engraftment of
murine marrow in experimental transplantation [71]. In
human clinical trials, the treatment of cord blood cells
with dimethyl PGE2 caused an increase in long-term en-
graftment [72], suggesting that a compound identified in
zebrafish could have clinical application in humans.
B) Zebrafish as an animal model for human diseases
Cardiovascular diseases
Model fish are excellent materials for the study of human
diseases due to some mutants display similar phenotypes
of human diseases [73]. In addition, essential genes and
thereof regulation to control the development of tissues or
organs are highly conserved [74]. For example, Tbx5 is a
T-box transcription factor responsible for cell-type specifi-
cation and morphogenesis. The phenotypes of tbx5 mu-
tant are highly similar among mammals and zebrafish.
Thus, transgenic fish with heart-specific fluorescence
could provide a high-through screening platform for drugs
for cardiovascular disease. For example, the Tsai’s lab
established a transgenic line which could be induced to
knock down the expression level of cardiac troponin C at
any developmental stage, including embryos, larva or
adult fish. The reduction of troponin C resulted in
mimicry of dilated cardiomyopathy, and the incomplete
atrioventricular blocking disease in humans. Therefore,
this transgenic line is expected to make a significant con-
tribution to drug screening and the elucidation of the mo-
lecular mechanisms underlying cardiovascular diseases.
Next, the effect of drugs on embryonic development was
also studied.
Amiodarone, which is a class III antiarrhythmic agent, is
being used for the treatment of tachyarrhythmia in
humans. However, Amiodarone-treated zebrafish embryos
were found to exhibit backflow of blood in the heart [75].
Subsequent research showed that Amiodarone caused fail-
ure of cardiac valve formation [75]. Specifically, Amioda-
rone induces ectopic expression of similar to versican b
(s-vcanb), resulting in repression of EGFR/GSK3β/Snail
signaling, which in turn, upregulates cdh5 at the heart
field, and causes defective cardiac valves [76]. Moreover,
Amiodarone was found to repress metastasis of breast
cancer cells by inhibiting the EGFR/ERK/Snail pathway
[77], a phenomenon analogous to the inhibitory effects of
Amiodarone on EMT transition observed in the heart.
Last but not least, although zebrafish has a two-
chambered heart, relative to mouse, rat, and rabbit, its
heart rate, action potential duration (APD) and electro-
cardiogram (ECG) morphology are similar to those of
humans. [78, 79]. Additionally, Tsai et al. demonstrated
that the in vitro ECG recording of zebrafish heart is a
simple, efficient and high throughput assay [80]. Thus,
zebrafish can serve as a platform for direct testing of
drug effect on APD prolongation and prolonged QT
interval, which is required by the FDA as a precondition
for drug approval.
Cancer study: melanoma
Zebrafish become a popular experimental animal for the
studies of human cancer [81], in part because the fish
homologs of human oncogenes and tumor suppressor
genes have been identified, and in part because signaling
pathways regulating cancer development are conserved
[82–84]. Amatruda et al. reported that many zebrafish
tumors are similar to those of human cancer in the
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histological examination [85]. The zebrafish transgenic
line with skin-specific red fluorescence could be applied
for skin tumor detection [86]. When the embryos of this
line were treated with solutions containing arsenic, the
tumors induced on the skin could be easily identified by
naked eye under fluorescent microscope. Therefore, this
transgenic line can be potentially used for the study of
skin diseases. For example, the common skin cancer
melanoma may be screened by the red fluorescence ex-
pression in this transgenic line.
Zebrafish transgenic line could also be applied to es-
tablish models simulating melanoma development. The
human oncogenic BRAFV600E was expressed under the
control of the zebrafish melanocyte mitfa promoter to
establish a melanoma model [87]. Combining skin-
specific red fluorescence with mitfa-driven oncogene ex-
pression, the melanoma could be easily traced. There-
fore, transgenic lines and mutants of model fish could
provide abundant resources for mechanistic studies and
therapeutic research in human diseases.
Cancer study: metastasis
Metastasis involves processes of sequential, interlinked
and selective steps, including invasion, intravasation, ar-
rest in distant capillaries, extravasation, and colonization
[88]. Zebrafish is again an alternative organism for in
vivo cancer biology studies. In particular, xenotransplant-
ation of human cancer cells into zebrafish embryos
serves as an alternative approach for evaluating cancer
progression and drug screening [89]. For example, hu-
man primary tumor cells labeled with fluorescence have
already been implanted in zebrafish liver, and the inva-
siveness and metastasis of these cells were directly ob-
servable and easily traceable [90]. To investigate the
mechanism of local cancer cell invasion, human glio-
blastoma cells labeled with fluorescence were infiltrated
into the brain of zebrafish embryos. It was observed that
the injected cells aligned along the abluminal surface of
brain blood vessels [91]. By grafting a small amount of
highly metastatic human breast carcinoma cells onto the
pericardial membrane of zebrafish embryos at 48 hpf,
tumor cells were observed to move longitudinally along
the aorta [92]. Similarly, highly metastatic human cancer
cells labeled with fluorescence were injected into the peri-
cardium of 48-hpf embryos. Afterwards, it is possible to
visualize how cancer cells entered the blood circulation and
arrested in small vessels in head and tail [93]. In another ex-
ample, zebrafish embryos were injected with tumorigenic
human glioma stem cells at different stages of metastasis,
including beginning, approaching, clustering, invading, mi-
grating, and transmigrating [94]. Thus, grafting a small
number of labeled tumor cells into transparent zebrafish
embryos allows us to dynamically monitor the cancer cells
without the interference of immune suppression.
Apart from its utility in analyzing the mechanisms of
tumor dissemination and metastasis, the zebrafish model
can also be applied to screen potential anticancer com-
pounds or drugs. In addition, zebrafish feature such ad-
vantages as easy gene manipulation, short generation
cycle, high reproducibility, low maintenance cost, and ef-
ficient plating of embryos [95, 96]. Therefore, this small
fish is second only to SCID and nude mice as xenograft
recipients of cancer cells.
Cancer study: leukemia
Leukemia is a cancer related to hematopoiesis. Most often,
leukemia results from the abnormal increase of white
blood cells. However, some human cancers of bone mar-
row and blood origins have their parental cells from other
blood cell types. The search for efficacious therapies for
leukemia is ongoing. Interestingly, the developmental pro-
cesses and genes related to hematopoiesis are similar be-
tween zebrafish and humans, making zebrafish a feasible
model for the study of leukemia. In addition, gene expres-
sion in zebrafish could be conveniently modified by sev-
eral approaches, e.g., MO-induced gene knockdown,
TALENs and CRISPR/Cas9 gene knockout, and DNA/
RNA introduced overexpression [6, 7]. In the study of Yeh
et al. [97], the zebrafish model was applied to screen for
chemical modifiers of AML1-ETO, an oncogenic fusion
protein prevalent in acute myeloid leukemia (AML).
Treatment of zebrafish with chemical modifiers of
AML1-ETO resulted in hematopoietic dysregulation and
elicited a malignant phenotype similar to human AML.
Cyclooxygenase-2 (COX2) is an enzyme causing inflamma-
tion and pain. Nimesulide is an inhibitor of COX2 and an
antagonist to AML1-ETO in hematopoietic differentiation.
FMS-like tyrosine kinase 3 (FLT3) is a class III receptor
tyrosine kinase which is normally expressed in human
hematopoietic stem and progenitor cells (HSPCs) [98].
Internal tandem duplication (ITD), which may occur at
either the juxtamembrane domain (JMD) or the tyrosine
kinase domain (TKDs) of FLT3, is observed in one-third
of human AML. Zebrafish Flt3 shares an overall 32, 35,
and 34% sequence identity with that of human, mouse,
and rat, respectively. However, the JMD and the activation
loops of TKD are highly conserved, implicating that the
functions of FLT3 signaling are evolutionally conserved.
Overexpression of human FLT3-ITD in zebrafish embryos
induces the ectopic expansion of FLT3-ITD positive mye-
loid cells. If those embryos are treated with AC220, a po-
tent and relatively selective inhibitor of FLT3, FLT3-ITD
myeloid expansion is effectively ameliorated [99]. In an-
other example, isocitrate dehydrogenase (IDH) 1 and 2
are involved in citric acid cycle in intermediary metabol-
ism. IDH mutations are found in approximately 30 % of
cytogenetically abnormal AML, suggesting a pathogenetic
link in leukemia initiation [100, 101]. Injection of either
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human IDH1-R132H or zebrafish idh1-R146H, a mutant
corresponding to human IDH1-R132H, resulted in in-
creased 2-hydroxyglutarate, which in turn induced the ex-
pansion of primitive myelopoiesis [102]. Taken together,
these reports suggest that the molecular pathways in-
volved in leukemia are conserved between humans and
zebrafish. Based on the aforementioned experimental evi-
dence, zebrafish can be an exceptional platform for mim-
icking human myelodysplastic syndromes and establishing
an in vivo vertebrate model for drug screening.
Cancer study: hepatoma
Several liver tumor models have been reported by liver-
specific expression of transgenic oncogenes such as kras,
xmrk and myc. These transgenic lines of zebrafish usually
generate liver tumors with various severity from hepato-
cellular adenoma (HCA) to hepatocellular carcinoma
(HCC) [103–105]. These three transgenic liver cancer
models have been used to identify differentially expressed
genes through RNA-SAGE sequencing. For example, re-
searchers have searched genes either up- or downregu-
lated among the three tumor models and analyzed the
possible signaling pathways. Then, correlation between
zebrafish liver tumor signatures and the different stages of
human hepatocarcinogenesis was determined [106]. High
tumor incidence and convenient chemical treatment make
this inducible transgenic zebrafish a plausible platform for
studying on liver tumor progression, regression, and anti-
cancer drug screening.
Behavioral studies
Interestingly, zebrafish become a modern organism
for studying on depressive disorders [107–109]. Be-
cause the physiological (neuroanatomical, neuroendo-
crine, neurochemical) and genetic characteristics of
zebrafish are similar to mammals, zebrafish are ideal
for high-throughput genetic and chemical genetic
screening. Furthermore, since behavioral test of zebrafish
for cognitive, approach-avoidance, and social paradigms
are available, the identification of depression-like indices
in response to physiological, genetic, environmental, and/
or psychopharmacological alterations is feasible [110].
Actually, zebrafish display highly robust phenotypes of
neurobehavioral disorders such as anxiety-like and ap-
proach–avoidance behaviors. Furthermore, novel informa-
tion of behavioral indices can be exposed, including
geotaxis via top-bottom vertical movement [111].
Zebrafish behavior can also be monitored using auto-
mated behavioral tracking software, which enhances
efficiency and reduces interrater variance [112]. Addition-
ally, zebrafish offer a potential insight into the social as-
pects of depression [113] and may be suitable for studying
the cognitive deficits of depression [114] and its putative
etiological pathways [115]. Last but not least, zebrafish are
highly sensitive to psychotropic drugs, such as antide-
pressants, anxiolytics, mood stabilizers, and antipsy-
chotics [116–118], serving as an important tool for
drug discovery.
C) Biosensor for environmental toxicants
Aromatic hydrocarbons, heavy metals and environmen-
tal estrogens are currently being used to test the impact
of environmental pollutants on animals [119]. These
studies mainly focused on mortality and abnormality
rates. However, the developing embryos may have
already been damaged in a subtle way that would have
precluded direct observation of morphology and detec-
tion of mortality. To overcome this drawback, transgenic
fish can be used because they are designed to study (a)
whether toxicants cause defective genes during embryo-
genesis; (b) whether pollutants affect the expression of
tissue-specific gene; and (c) whether the impact of pol-
lutants on embryonic development is dosage dependent.
Pollutants can be directly detected by simply observing
the coloration change of cells before or after the pollut-
ants can cause morphological damage. Therefore, trans-
genic model fish are promising organisms for use as
bioindicators to environmental toxicants and mutagens
[120, 121]. In addition, Chen and Lu reported that the
environmental xenobiotics can be detected by a trans-
genic line of medaka carrying a GFP reporter driven by
cytochrome P450 1a promoter (CYP1A-GFP) [122]. Fur-
thermore, the environmental xenoestrogenic compounds
can be specifically detected by a hybrid transgenic line
derived from crossing between line CYP1A-GFP and line
VG-Lux whose Lux reporter activity is driven by a vitello-
genin promoter [123]. Lee et al. reported another zebrafish
transgenic line, termed huORFZ [54], as it has been de-
scribed in pervious section . At normal condition, the
translation of the transferred huORFchop-gfp mRNA in
huORFZ embryos is completely suppressed by an inhibi-
tory uORF of human chop mRNA (huORFchop). However,
when the huORFZ embryos were under ER stress, such as
heat shock, cold shock, hypoxia, metals, alcohol, toxi-
cants or drugs, the downstream GFP became apparent
due to the blockage of huORFchop-mediated translation in-
hibition. Therefore, huORFZ embryos can be used to
study the mechanism of translational inhibition. Addition-
ally, huORFZ embryos can serve a living material to moni-
tor the contamination of hazardous pollutants [124].
Besides the universal huORFZ system, zebrafish could also
be indicators for specific pollutants. For example, Xu et al.
reported a transgenic zebrafish Tg (cyp1a:gfp) which can
serve as an in vivo assay for screening xenobiotic com-
pounds, since Cyp1a is involved in the aryl hydrocarbon
receptor pathway, and can be induced in the presence of
Dioxins/Dioxin-like compounds and polycyclic aromatic
hydrocarbons [125]. Additional advantages of zebrafish
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include the small size, abundant number, rapid develop-
ment and transparent eggs. These features make this
model fish more accessible for the studies of molecular
toxicology.
Conclusion
It is increasingly clear that the transgenic fish model is a
powerful biomaterial for the studies of multiple disci-
plines, including molecular biology, developmental biol-
ogy, neurobiology, cancer biology and regenerative
medicine. It provides a simple, yet effective, in vivo ap-
proach to identify regulatory DNA sequences, as well as
determine gene function and molecular pathways. More
importantly, an increasing number of papers have re-
ported that (a) the defective phenotype of mutants of
model fish can photocopy with known human disorders;
and (b) drugs have similar effects on zebrafish and mam-
malian systems. Therefore, the transgenic fish model of-
fers a useful platform for high-throughput drug
screening in biomedical sciences. Additionally, it can
serve as an environmental indicator for detecting pollut-
ants in our daily lives.
Nevertheless, there are several limitations and caveats
of this fish model. First, unlike mammals, fish lack the
heart septation, lung, mammary gland, prostate gland
and limbs, which make the fish model impossible for
studies of these tissues and organs. Additionally, fish are
absent of placenta so that fish embryos are directly ex-
posed to the environment (e.g., drugs or pollutants)
without involving the placenta. Second, fish are poikilo-
thermic and usually maintained below 30 °C, which may
not be optimal for those mammalian agents adapted for
37 °C in evolution. Last, since the zebrafish genome is
tetraploid, it is less straight forward to conduct loss-of-
function studies for certain genes.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HJT conceptualized, organized, charged and revised the content, and HJT,
CYL and CYC wrote the manuscript together. All authors read and approved
the final manuscript.
Acknowledgments
This work was supported by the Ministry of Science and Technology, R. O. C.
(104-2321-B-715-001).
Received: 1 November 2015 Accepted: 20 January 2016
Published: 28 January 2016
References
1. Hackett PB. The molecular biology of transgenic fish. In: Hochachka PW,
Mommsen TP, editors. Biochemistry and Molecular Biology of Fishes.
Amsterdam: Elsevier Science; 1993. p. 207–40.
2. Hsiao CD, Hsieh FJ, Tsai HJ. Enhanced expression and stable transmission of
transgenes flanked by inverted terminal repeats from adeno-associated
virus in zebrafish. Dev Dyn. 2001;220:323–36.
3. Kawakami K, Shima A. Identification of the Tol2 transposase of the medaka
fish Oryzias latipes that catalyzes excision of a nonautonomous Tol2
element in zebrafish Danio rerio. Gene. 1999;240:239–44.
4. Urasaki A, Morvan G, Kawakami K. Functional dissection of the Tol2
transposable element identified the minimal cis-sequence and a highly
repetitive sequence in the subterminal region essential for transposition.
Genetics. 2006;174:639–49.
5. Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. A
transposon-mediated gene trap approach identifies developmentally
regulated genes in zebrafish. Dev Cell. 2004;7:133–44.
6. Huang P, Xiao A, Zhou M, Zhu Z, Lin S, Zhang B. Heritable gene targeting in
zebrafish using customized TALENs. Nat Biotechnol. 2011;29:699–700.
7. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, et al. Efficient genome
editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013;31:227–9.
8. Auer TO, Del Bene F. CRISPR/Cas9 and TALEN-mediated knock-in
approaches in zebrafish. Methods. 2014;69:142–50.
9. Amsterdam A, Lin S, Hopkins N. The Aequorea victoria green fluorescent protein
can be used as a reporter in live zebrafish embryos. Dev Biol. 1995;171:123–9.
10. Long Q, Meng A, Wang H, Jessen JR, Farrell MJ, Lin S. GATA-1 expression
pattern can be recapitulated in living transgenic zebrafish using GFP
reporter gene. Development. 1997;124:4105–11.
11. Higashijima S, Okamoto H, Ueno N, Hotta Y, Eguchi G. High-frequency
generation of transgenic zebrafish which reliably express GFP in whole
muscles or the whole body by using promoters of zebrafish origin. Dev Biol.
1997;192:289–99.
12. Kennedy BN, Vihtelic TS, Checkley L, Vaughan KT, Hyde DR. Isolation of a
zebrafish rod opsin promoter to generate a transgenic zebrafish line
expressing enhanced green fluorescent protein in rod photoreceptors. J
Biol Chem. 2001;276:14037–43.
13. Higashijima S, Hotta Y, Okamoto H. Visualization of cranial motor neurons in
live transgenic zebrafish expressing green fluorescent protein under the
control of the islet-1 promoter/enhancer. J Neurosci. 2000;20:206–18.
14. Huang H, Vogel SS, Liu N, Melton DA, Lin S. Analysis of pancreatic
development in living transgenic zebrafish embryos. Mol Cell Endocrinol.
2001;177:117–24.
15. Huang CJ, Tu CT, Hsiao CD, Hsieh FJ, Tsai HJ. Germ-line transmission of a
myocardium-specific GFP transgene reveals critical regulatory elements in the
cardiac myosin light chain 2 promoter of zebrafish. Dev Dyn. 2003;228:30–40.
16. Her GM, Yeh YH, Wu JL. 435-bp liver regulatory sequence in the liver fatty
acid binding protein (L-FABP) gene is sufficient to modulate liver regional
expression in transgenic zebrafish. Dev Dyn. 2003;227:347–56.
17. Kim YI, Lee S, Jung SH, Kim HT, Choi JH, Lee MS, et al. Establishment of a
bone-specific col10a1: GFP transgenic zebrafish. Mol Cells. 2013;36:145–50.
18. Walton EM, Cronan MR, Beerman RW, Tobin DM. The macrophage-specific
promoter mfap4 allows live, long-term analysis of macrophage behavior
during mycobacterial infection in zebrafish. PLoS One. 2015;10, e0138949.
19. Krøvel AV, Olsen LC. Expression of a vas:: EGFP transgene in primordial germ
cells of the zebrafish. Mech Dev. 2002;116:141–50.
20. Chou CY, Horng LS, Tsai HJ. Uniform GFP-expression in transgenic medaka
(Oryzias latipes) at the F0 generation. Transgenic Res. 2001;10:303–15.
21. Holden C, Bhattacharjee Y. Random samples: That special glow. Science.
2003;300:1368.
22. Dean J. Genetics: Fish that glow in Taiwan. Far Eastern Economic Review.
2003;8:38.
23. Buechner MM, Grossman L, Hamilton A. Coolest inventions 2003: Light and
dark-Red fish, blue fish and Glow-in-dark fish. TIME. 2003;24:68–9.
24. Jessen JR, Meng A, McFarlane RJ, Paw BH, Zon LI, Smith GR, et al.
Modification of bacterial artificial chromosomes through chi-stimulated
homologous recombination and its application in zebrafish transgenesis.
Proc Natl Acad Sci U S A. 1998;95:5121–6.
25. Jessen JR, Willett CE, Lin S. Artificial chromosome transgenesis reveals long-
distance negative regulation of rag1 in zebrafish. Nat Genet. 1999;23:15–6.
26. Chen YH, Wang YH, Chang MY, Lin CY, Weng CW, Westerfield M, et al. Multiple
upstream modules regulate zebrafish myf5 expression. BMC Dev Biol. 2007;7:1.
27. Scheer N, Campos-Ortega JA. Use of the GAL4-UAS technique for targeted
gene expression in zebrafish. Mech Dev. 1999;80:153–8.
28. Walsh EC, Stainier DY. UDP-glucose dehydrogenase required for cardiac
valve formation in zebrafish. Science. 2001;293:1670–3.
29. Raya A, Koth CM, Büscher D, Kawakami Y, Itoh T, Raya RM, et al. Activation
of Notch signaling pathway precedes heart regeneration in zebrafish. Proc
Natl Acad Sci U S A. 2003;100 Suppl 1:11889–95.
Lin et al. Journal of Biomedical Science  (2016) 23:19 Page 9 of 11
30. Shu X, Cheng K, Patel N, Chen F, Joseph E, Tsai HJ, et al. Na, K-ATPase is
essential for embryonic heart development in the zebrafish. Development.
2003;130:6165–73.
31. Forouhar AS, Liebling M, Hickerson A, Nasiraei-Moghaddam A, Tsai HJ, Hove
JR, et al. The embryonic vertebrate heart tube is a dynamic suction pump.
Science. 2006;312:751–3.
32. Liebling M, Forouhar AS, Gharib M, Fraser SE, Dickinson ME. Four-dimensional
cardiac imaging in living embryos via postacquisition synchronization of
nongated slice sequences. J Biomed Opt. 2005;10:054001.
33. Hami D, Grimes AC, Tsai HJ, Kirby ML. Zebrafish cardiac development
requires a conserved secondary heart field. Development. 2011;138:2389–98.
34. Nevis K, Obregon P, Walsh C, Guner-Ataman B, Burns CG, Burns CE. Tbx1 is
required for second heart field proliferation in zebrafish. Dev Dyn. 2013;242:550–9.
35. Chen YH, Lee HC, Liu CF, Lin CY, Tsai HJ. Novel regulatory sequence − 82/-
62 functions as a key element to drive the somite-specificity of zebrafish
myf-5. Dev Dyn. 2003;228:41–50.
36. Lee HC, Huang HY, Lin CY, Chen YH, Tsai HJ. Foxd3 mediates zebrafish myf5
expression during early somitogenesis. Dev Biol. 2006;290:359–72.
37. Lee HC, Tseng WA, Lo FY, Liu TM, Tsai HJ. FoxD5 mediates anterior-posterior
polarity through upstream modulator Fgf signaling during zebrafish
somitogenesis. Dev Biol. 2009;336:232–45.
38. Wang YH, Li CK, Lee GH, Tsay HJ, Tsai HJ, Chen YH. Inactivation of zebrafish
mrf4 leads to myofibril misalignment and motor axon growth
disorganization. Dev Dyn. 2008;237:1043–50.
39. Lin CY, Chen YH, Lee HC, Tsai HJ. Novel cis-element in intron 1 represses
somite expression of zebrafish myf-5. Gene. 2004;334:63–72.
40. Lin CY, Chen JS, Loo MR, Hsiao CC, Chang WY, Tsai HJ. MicroRNA-3906
regulates fast muscle differentiation through modulating the target gene
homer-1b in zebrafish embryos. PLoS One. 2013;8:e70187.
41. Hsu RJ, Lin CY, Hoi HS, Zheng SK, Lin CC, Tsai HJ. Novel intronic microRNA
represses zebrafish myf5 promoter activity through silencing dickkopf-3
gene. Nucleic Acids Res. 2010;38:4384–93.
42. Fu CY, Su YF, Lee MH, Chang GD, Tsai HJ. Zebrafish Dkk3a protein regulates
the activity of myf5 promoter through interaction with membrane receptor
integrin α6b. J Biol Chem. 2012;287:40031–42.
43. Hsu RJ, Lin CC, Su YF, Tsai HJ. dickkopf-3-related gene regulates the
expression of zebrafish myf5 gene through phosphorylated p38a-
dependent Smad4 activity. J Biol Chem. 2011;286:6855–64.
44. Lin CY, Yung RF, Lee HC, Chen WT, Chen YH, Tsai HJ. Myogenic regulatory
factors Myf5 and Myod function distinctly during craniofacial myogenesis of
zebrafish. Dev Biol. 2006;299:594–608.
45. Lin CY, Chen WT, Lee HC, Yang PH, Yang HJ, Tsai HJ. The transcription
factor Six1a plays an essential role in the craniofacial myogenesis of
zebrafish. Dev Biol. 2009;331:152–66.
46. Lin CY, Lee HC, Chen HC, Hsieh CC, Tsai HJ. Normal function of Myf5 during
gastrulation is required for pharyngeal arch cartilage development in
zebrafish embryos. Zebrafish. 2013;10:486–99.
47. Hinits Y, Osborn DP, Hughes SM. Differential requirements for myogenic
regulatory factors distinguish medial and lateral somitic, cranial and fin
muscle fibre populations. Development. 2009;136:403–14.
48. Ma GC, Wang TM, Su CY, Wang YL, Chen S, Tsai HJ. Retina-specific cis-
elements and binding nuclear proteins of carp rhodopsin gene. FEBS Lett.
2001;508:265–71.
49. Hu CY, Yang CH, Chen WY, Huang CJ, Huang HY, Chen MS, et al. Egr1 gene
knockdown affects embryonic ocular development in zebrafish. Mol Vis.
2006;12:1250–8.
50. Huang HY, Dai ES, Liu JT, Tu CT, Yang TC, Tsai HJ. The embryonic expression
patterns and the knockdown phenotypes of zebrafish ADP-ribosylation
factor-like 6 interacting protein gene. Dev Dyn. 2009;238:232–40.
51. Huang HY, Liu JT, Yan HY, Tsai HJ. Arl6ip1 plays a role in proliferation during
zebrafish retinogenesis. Cells Tissues Organs. 2012;196:161–74.
52. Tu CT, Yang TC, Huang HY, Tsai HJ. Zebrafish arl6ip1 is required for neural
crest development during embryogenesis. PLoS One. 2012;7:e32899.
53. Lin CY, Huang HY, Lu PN, Lin CW, Lu KM, Tsai HJ. Ras-related nuclear
protein is required for late developmental stages of retinal cells in zebrafish
eyes. Int J Dev Biol 2015;59:435–42.
54. Lee HC, Chen YJ, Liu YW, Lin KY, Chen SW, Lin CY, et al. Transgenic
zebrafish model to study translational control mediated by upstream open
reading frame of human chop gene. Nucleic Acids Res. 2011;39:e139.
55. Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation
by miRNAs. Science. 2011;331:550–3.
56. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of
translational repression and mRNA decay. Nat Rev Genet. 2011;12:99–110.
57. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and
stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.
58. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell.
2009;136:215–33.
59. Rajewsky N. microRNA target predictions in animals. Nat Genet. 2006;38:S8–S13.
60. Hsu RJ, Yang HJ, Tsai HJ. Labeled microRNA pull-down assay system: an
experimental approach for high-throughput identification of microRNA-
target mRNAs. Nucleic Acids Res. 2009;37:e77.
61. Stahlhut C, Suárez Y, Lu J, Mishima Y, Giraldez AJ. miR-1 and miR-206
regulate angiogenesis by modulating VegfA expression in zebrafish.
Development. 2012;139:4356–64.
62. Lin CY, Lee HC, Fu CY, Ding YY, Chen JS, Lee MH, et al. MiR-1 and miR-206
target different genes to have opposing roles during angiogenesis in
zebrafish embryos. Nat Commun. 2013;4:2829.
63. Frith JE, Porrello ER, Cooper-White JJ. Concise review: new frontiers in
microRNA-based tissue regeneration. Stem Cells Transl Med. 2014;3:969–76.
64. Ujigo S, Kamei N, Hadoush H, Fujioka Y, Miyaki S, Nakasa T, et al.
Administration of microRNA-210 promotes spinal cord regeneration in mice.
Spine (Phila Pa 1976). 2014;39:1099–107.
65. Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D,
et al. Regulation of neonatal and adult mammalian heart regeneration by
the miR-15 family. Proc Natl Acad Sci U S A. 2013;110:187–92.
66. Fuller-Carter PI, Carter KW, Anderson D, Harvey AR, Giles KM, Rodger J.
Integrated analyses of zebrafish miRNA and mRNA expression profiles
identify miR-29b and miR-223 as potential regulators of optic nerve
regeneration. BMC Genomics. 2015;16:591.
67. Traver D, Paw BH, Poss KD, Penberthy WT, Lin S, Zon LI. Transplantation and
in vivo imaging of multilineage engraftment in zebrafish bloodless mutants.
Nat Immunol. 2003;4:1238–46.
68. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell
biology. Cell. 2008;132:631–44.
69. Hsia N, Zon LI. Transcriptional regulation of hematopoietic stem cell
development in zebrafish. Exp Hematol. 2005;33:1007–14.
70. Weber GJ, Choe SE, Dooley KA, Paffett-Lugassy NN, Zhou Y, Zon LI. Mutant-
specific gene programs in the zebrafish. Blood. 2005;106:521–30.
71. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, et al.
Prostaglandin E2 regulates vertebrate haematopoietic stem cell
homeostasis. Nature. 2007;447:1007–11.
72. Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey M, et al.
Prostaglandin E2 enhances human cord blood stem cell xenotransplants
and shows long-term safety in preclinical nonhuman primate transplant
models. Cell Stem Cell. 2011;8:445–58.
73. Shin JT, Fishman MC. From Zebrafish to human: modular medical models.
Annu Rev Genomics Hum Genet. 2002;3:311–40.
74. Garrity DM, Childs S, Fishman MC. The heartstrings mutation in zebrafish
causes heart/fin Tbx5 deficiency syndrome. Development. 2002;129:4635–45.
75. Chen YH, Lee HC, Hsu RJ, Chen TY, Huang YK, Lo HC, et al. The toxic effect
of Amiodarone on valve formation in the developing heart of zebrafish
embryos. Reprod Toxicol. 2012;33:233–44.
76. Lee HC, Lo HC, Lo DM, Su MY, Hu JR, Wu CC, et al. Amiodarone induces
overexpression of similar to versican b to repress the EGFR/Gsk3b/Snail
signaling axis during cardiac valve formation of zebrafish embryos. PloS
One 2015;10:e0144751.
77. Lee HC, Su MY, Lo HC, Wu CC, Hu JR, Lo DM, et al. Cancer metastasis and
EGFR signaling is suppressed by Amiodarone-induced Versican V2.
Oncotarget 2015;6:42976–87.
78. Milan DJ, Jones IL, Ellinor PT, MacRae CA. In vivo recording of adult
zebrafish electrocardiogram and assessment of drug-induced QT
prolongation. Am J Physiol Heart Circ Physiol. 2006;291:H269–73.
79. Arnaout R, Ferrer T, Huisken J, Spitzer K, Stainier DY, Tristani-Firouzi M, et al.
Zebrafish model for human long QT syndrome. Proc Natl Acad Sci U S A.
2007;104:11316–21.
80. Tsai CT, Wu CK, Chiang FT, Tseng CD, Lee JK, Yu CC, et al. In-vitro recording
of adult zebrafish heart electrocardiogram - a platform for pharmacological
testing. Clin Chim Acta. 2011;412:1963–7.
81. Lu JW, Hsia Y, Tu HC, Hsiao YC, Yang WY, Wang HD, et al. Liver development and
cancer formation in zebrafish. Birth Defects Res C Embryo Today. 2011;93:157–72.
82. Feitsma H, Cuppen E. Zebrafish as a cancer model. Mol Cancer Res.
2008;6:685–94.
Lin et al. Journal of Biomedical Science  (2016) 23:19 Page 10 of 11
83. Payne E, Look T. Zebrafish modelling of leukaemias. Br J Haematol.
2009;146:247–56.
84. Stoletov K, Klemke R. Catch of the day: zebrafish as a human cancer model.
Oncogene. 2008;27:4509–20.
85. Amatruda JF, Shepard JL, Stern HM, Zon LI. Zebrafish as a cancer model
system. Cancer Cell. 2002;1:229–31.
86. Wang YH, Chen YH, Wu TN, Lin YJ, Tsai HJ. A keratin 18 transgenic zebrafish
Tg(k18(2.9):RFP) treated with inorganic arsenite reveals visible
overproliferation of epithelial cells. Toxicol Lett. 2006;163:191–7.
87. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD,
et al. BRAF mutations are sufficient to promote nevi formation and
cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15:249–54.
88. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’
hypothesis revisited. Nat Rev Cancer. 2003;3:453–8.
89. Zhang B, Xuan C, Ji Y, Zhang W, Wang D. Zebrafish xenotransplantation as a
tool for in vivo cancer study. Fam Cancer. 2015;14:487–93.
90. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, et al.
Metastatic behaviour of primary human tumours in a zebrafish
xenotransplantation model. BMC Cancer. 2009;9:128.
91. Lal S, La Du J, Tanguay RL, Greenwood JA. Calpain 2 is required for the
invasion of glioblastoma cells in the zebrafish brain microenvironment.
J Neurosci Res. 2012;90:769–81.
92. Zhao C, Yang H, Shi H, Wang X, Chen X, Yuan Y, et al. Distinct contributions
of angiogenesis and vascular co-option during the initiation of primary
microtumors and micrometastases. Carcinogenesis. 2011;32:1143–50.
93. Stoletov K, Kato H, Zardouzian E, Kelber J, Yang J, Shattil S, et al. Visualizing
extravasation dynamics of metastatic tumor cells. J Cell Sci. 2010;123:2332–41.
94. Yang XJ, Cui W, Gu A, Xu C, Yu SC, Li TT, et al. A novel zebrafish
xenotransplantation model for study of glioma stem cell invasion. PLoS
One. 2013;8:e61801.
95. Zhang B, Shimada Y, Kuroyanagi J, Umemoto N, Nishimura Y, Tanaka T.
Quantitative phenotyping-based in vivo chemical screening in a zebrafish
model of leukemia stem cell xenotransplantation. PLoS One. 2014;9:e85439.
96. Shimada Y, Nishimura Y, Tanaka T. Zebrafish-based systems pharmacology
of cancer metastasis. Methods Mol Biol. 2014;1165:223–38.
97. Yeh JR, Munson KM, Elagib KE, Goldfarb AN, Sweetser DA, Peterson RT.
Discovering chemical modifiers of oncogene-regulated hematopoietic
differentiation. Nat Chem Biol. 2009;5:236–43.
98. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, et al. STK-1, the
human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human
bone marrow cells and is involved in the proliferation of early progenitor/
stem cells. Proc Natl Acad Sci U S A. 1994;91:459–63.
99. He BL, Shi X, Man CH, Ma AC, Ekker SC, Chow HC, et al. Functions of flt3 in
zebrafish hematopoiesis and its relevance to human acute myeloid
leukemia. Blood. 2014;123:2518–29.
100. Gross S, Cairns RA, Minden MD, Driggers EM, Bittinger MA, Jang HG, et al.
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute
myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.
J Exp Med. 2010;207:339–44.
101. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev
Cancer. 2011;11:85–95.
102. Shi X, He BL, Ma AC, Guo Y, Chi Y, Man CH, et al. Functions of idh1 and its
mutation in the regulation of developmental hematopoiesis in zebrafish.
Blood. 2015;125:2974–84.
103. Li Z, Huang X, Zhan H, Zeng Z, Li C, Spitsbergen JM, et al. Inducible and
repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk
transgenic zebrafish. J Hepatol. 2012;56:419–25.
104. Nguyen AT, Emelyanov A, Koh CH, Spitsbergen JM, Parinov S, Gong Z. An
inducible kras (V12) transgenic zebrafish model for liver tumorigenesis and
chemical drug screening. Dis Model Mech. 2012;5:63–72.
105. Li Z, Zheng W, Wang Z, Zeng Z, Zhan H, Li C, et al. A transgenic zebrafish
liver tumor model with inducible Myc expression reveals conserved Myc
signatures with mammalian liver tumors. Dis Model Mech. 2013;6:414–23.
106. Zheng W, Li Z, Nguyen AT, Li C, Emelyanov A, Gong Z. Xmrk, kras and myc
transgenic zebrafish liver cancer models share molecular signatures with
subsets of human hepatocellular carcinoma. PLoS One. 2014;9, e91179.
107. Kalueff AV, Echevarria DJ, Stewart AM. Gaining translational momentum:
more zebrafish models for neuroscience research. Prog
Neuropsychopharmacol Biol Psychiatry. 2014;55:1–6.
108. Kalueff AV, Stewart AM, Gerlai R. Zebrafish as an emerging model for
studying complex brain disorders. Trends Pharmacol Sci. 2014;35:63–75.
109. Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV. Zebrafish
models for translational neuroscience research: from tank to bedside.
Trends Neurosci. 2014;37:264–78.
110. Fonseka TM, Wen XY, Foster JA, Kennedy SH. Zebrafish models of major
depressive disorders. J Neurosci Res. 2016;94:3–14.
111. Cachat J, Stewart A, Utterback E, Hart P, Gaikwad S, Wong K, et al. Three-
dimensional neurophenotyping of adult zebrafish behavior. PLoS One. 2011;
6:e17597.
112. Nguyen M, Stewart AM, Kalueff AV. Aquatic blues: modeling depression and
antidepressant action in zebrafish. Prog Neuropsychopharmacol Biol
Psychiatry. 2014;55:26–39.
113. Teles MC, Dahlbom SJ, Winberg S, Oliveira RF. Social modulation of brain
monoamine levels in zebrafish. Behav Brain Res. 2013;253:17–24.
114. Karnik I, Gerlai R. Can zebrafish learn spatial tasks? An empirical analysis of
place and single CS-US associative learning. Behav Brain Res. 2012;233:415–21.
115. Carvalho AF, Miskowiak KK, Hyphantis TN, Kohler CA, Alves GS, Bortolato B,
et al. Cognitive dysfunction in depression-pathophysiology and novel
targets. CNS Neurol Disord Drug Targets. 2014;13:1819–35.
116. Ellis LD, Soanes KH. A larval zebrafish model of bipolar disorder as a
screening platform for neuro-therapeutics. Behav Brain Res. 2012;233:450–7.
117. Maximino C, Puty B, Benzecry R, Araújo J, Lima MG, De Jesus Oliveira Batista
E, et al. Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with
serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine
and para-chlorophenylalanine (pCPA) in two behavioral models.
Neuropharmacology. 2013;71:83–97.
118. Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA, et al.
An affective disorder in zebrafish with mutation of the glucocorticoid
receptor. Mol Psychiatry. 2013;18:681–91.
119. Schwarzenbach RP, Egli T, Hofstetter TB, Von Gunten U, Wehrli B. Global
Water Pollution and Human Health. Annu Rev Env Resour. 2010;35:109–36.
120. Amanuma K, Takeda H, Amanuma H, Aoki Y. Transgenic zebrafish for
detecting mutations caused by compounds in aquatic environments.
Nat Biotechnol. 2000;18:62–5.
121. Amanuma K, Tone S, Saito H, Shigeoka T, Aoki Y. Mutational spectra of
benzo [a] pyrene and MeIQx in rpsL transgenic zebrafish embryos. Mutat
Res. 2002;513:83–92.
122. Chen T, Lu JK. Transgenic fish technology: basic principles and their
application in basic and applied research. In: De la Fuente J, Castro FO,
editors. Gene Transfer in Aquatic Organism. Berlin: Springer; 1998; p. 45–73.
123. Ng GH, Gong Z. GFP transgenic medaka (Oryzias latipes) under the
inducible cyp1a promoter provide a sensitive and convenient biological
indicator for the presence of TCDD and other persistent organic chemicals.
PLoS One. 2013;8:e64334.
124. Lee HC, Lu PN, Huang HL, Chu C, Li HP, Tsai HJ. Zebrafish transgenic line
huORFZ is an effective living bioindicator for detecting environmental
toxicants. PLoS One. 2014;9:e90160.
125. Xu H, Li C, Li Y, Ng GH, Liu C, Zhang X, et al. Generation of Tg (cyp1a:gfp)
transgenic zebrafish for development of a convenient and sensitive in vivo assay
for aryl hydrocarbon receptor activity. Mar Biotechnol (NY). 2015;17:831–40.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lin et al. Journal of Biomedical Science  (2016) 23:19 Page 11 of 11
